Synthesis and immunosuppressive activity of new artemisinin derivatives. Part 2: 2-[12(β or α)-Dihydroartemisinoxymethyl(or 1′-ethyl)]phenoxyl propionic acids and esters

Bioorganic and Medicinal Chemistry

Volumn 14, Issue 23, 2006, Pages 8043-8049

  Yang, Zhong Shun ^a   Wang, Jun Xia ^a   Zhou, Yu ^a   Zuo, Jian Ping ^a   Li, Ying ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Artemisinin derivatives; Immunosuppressive activity; Inhibitory effect; Synthesis

Indexed keywords

2 [3 (12ALPHA ARTEMISINOXYMETHYL)]PHENOXYLPROPIONIC ACID; 2 [3 (12BETA ARTEMISINOXYMETHYL)]PHENOXYLPROPIONIC ACID; 2 [4 (12ALPHA ARTEMISINOXYMETHYL)]PHENOXYLPROPIONIC ACID; 2 [4 (12BETA ARTEMISINOXYMETHYL) 1' ETHYL]PHENOXYLPROPIONIC ACID; 2 [4 (12BETA ARTEMISINOXYMETHYL)]PHENOXYLPROPIONIC ACID; 2 [4 (2 ARTEMISINOXYMETHYL) 1' ETHYL]PHENOXYLPROPIONIC ACID; 2 METHOXYPHENYL 2 [3 (12BETA ARTEMISINOXYMETHYL)]PHENOXYLPROPIONATE; 2 METHOXYPHENYL 2 [4 (12BETA ARTEMISINOXYMETHYL) 1' ETHYL] PHENOXYLPROPIONATE; 2 METHOXYPHENYL 2 [4 (12BETA ARTEMISINOXYMETHYL)]PHENOXYLPROPIONATE; ARTEMISININ DERIVATIVE; CONCANAVALIN A; ETHYL 2 [3 (12ALPHA ARTEMISINOXYMETHYL)]PHENOXYLPROPIONATE; ETHYL 2 [3 (12BETA ARTEMISINOXYMETHYL)]PHENOXYLPROPIONATE; ETHYL 2 [4 (12 ARTEMISINOXYMETHYL) 1' ETHYL]PHENOXYLPROPIONATE; ETHYL 2 [4 (12 BETAARTEMISINOXYMETHYL) 1' ETHYL]PHENOXYLPROPIONATE; ETHYL 2 [4 (12ALPHA ARTEMISINOXYMETHYL)]PHENOXYLPROPIONATE; ETHYL 2 [4 (12BETA ARTEMISINOXYMETHYL)]PHENOXYLPROPIONATE; LIPOPOLYSACCHARIDE; MITOGENIC AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENCY; DRUG SYNTHESIS; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOTOXICITY; MALE; NONHUMAN; SPLEEN LYMPHOCYTE; T LYMPHOCYTE;

ARTEMISININS; B-LYMPHOCYTES; CELL PROLIFERATION; CONCANAVALIN A; ESTERS; IMMUNOSUPPRESSIVE AGENTS; LIPOPOLYSACCHARIDES; LYMPHOCYTES; PROPIONIC ACIDS; SESQUITERPENES; SPLEEN;

EID: 33751021384     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2006.07.038     Document Type: Article

References (11)

1. Qian R.Sh., Li Zh.L., Yu J.L., and Ma D.J. Zhong Yi Za Zhi 22 (1981) 63
2. Zhuang G.K., Zou M.X., Xu X., and Zhu Y. Zhong Hua Yi Xue Za Zhi 62 (1982) 365
3. Huang G.J., and Zhao Y. Zhong Yi Za Zhi 3 (1983) 171
4. Shen M., Ge H.L., He Y.X., Song Q.L., and Zhang H.Z. Sci. Sin. [B]. 27 (1984) 398
5. Sun X.Z., Xie Sh.Sh., Long Zh.Zh., Zhang Zh.R., and Tu Y.Y. Zhong Yi Za Zhi 11 (1991) 37
6. Lin P.Y., Pan J.Q., Feng Z.M., Zhang D., and Xiao L.Y. Comparison of immunopharmacologic action of artemisinin and its derivatives. In: Zhou J.H., Li X.Y., and Rong K.T. (Eds). Progress in Immuno-pharmacology (1993), Chinese Science and Technique Press, Beijing 325
7. Yu Q.B., and Gao Y.X. Zhongguo Pi Fu Xing Bing Xue Za Zhi 30 (1997) 51
8. Yang Z.S., Zhou W.L., Sui Y., Wang J.X., Wu J.M., Zhou Y., Zhang Y., He P.L., Han J.Y., Tang W., Zuo J.P., and Li Y. J. Med. Chem. 48 (2005) 4608
9. Li Y., Yu P.L., Chen Y.X., Li L.Q., Gai Y.Z., Wang D.S., and Zhang Y.P. Acta Pharm. Sin. 16 (1981) 429
10. Hazeldine S.T., Polin L., Kushner J., Paluch J., White K., Edelstein M., Palomino E., Corbett T.H., and Horwitz J.P. J. Med. Chem. 44 (2001) 1758
11. Feng Y.H., Zhou W.L., Wu Q.L., Li X.Y., Zhao W.M., and Zuo J.P. Acta Pharmacol. Sin. 23 (2002) 893